Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre Nationwide Cohort - Gecse, K B; Lovász, B D; Farkas, K (J Crohns Colitis, 2016)
et al.